LEADER 03922nam  22006735  450 
001 9910254047703321
005 20200702144344.0
010   $a3-319-39926-8
024 7 $a10.1007/978-3-319-39926-3
035   $a(CKB)3710000000734984
035   $a(DE-He213)978-3-319-39926-3
035   $a(MiAaPQ)EBC4568533
035   $a(PPN)194379213
035   $a(EXLCZ)993710000000734984
100   $a20160623d2016      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aNovel Therapeutic Approaches to the Treatment of Parkinson?s Disease $eAn Overview and Update /$fedited by Corey R. Hopkins
205   $a1st ed. 2016.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016.
215   $a1 online resource (VII, 151 p. 20 illus., 10 illus. in color.) 
225 1 $aTopics in Medicinal Chemistry,$x1862-2461 ;$v18
311   $a3-319-39924-1 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aAdenosine A2A Receptor Antagonists -- Targeting ?-Synuclein as a Parkinson?s Disease Therapeutic -- Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors.
330   $aMedicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors.
410  0$aTopics in Medicinal Chemistry,$x1862-2461 ;$v18
606   $aMedicinal chemistry
606   $aMedical biochemistry
606   $aProteins 
606   $aMolecular biology
606   $aNeurochemistry
606   $aMedicinal Chemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/C28000
606   $aMedical Biochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/H35005
606   $aReceptors$3https://scigraph.springernature.com/ontologies/product-market-codes/L14110
606   $aMolecular Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B1700X
606   $aNeurochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/B18010
615  0$aMedicinal chemistry.
615  0$aMedical biochemistry.
615  0$aProteins .
615  0$aMolecular biology.
615  0$aNeurochemistry.
615 14$aMedicinal Chemistry.
615 24$aMedical Biochemistry.
615 24$aReceptors.
615 24$aMolecular Medicine.
615 24$aNeurochemistry.
676   $a616.83306
702   $aHopkins$b Corey R$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910254047703321
996   $aNovel Therapeutic Approaches to the Treatment of Parkinson?s Disease$92545270
997   $aUNINA